Provided by Tiger Fintech (Singapore) Pte. Ltd.

Heron Therapeutics

2.03
+0.10005.18%
Post-market: 2.050.0200+0.99%19:52 EDT
Volume:725.74K
Turnover:1.43M
Market Cap:309.70M
PE:-36.18
High:2.03
Open:1.94
Low:1.90
Close:1.93
Loading ...

Loss-Making Heron Therapeutics, Inc. (NASDAQ:HRTX) Expected To Breakeven In The Medium-Term

Simply Wall St.
·
29 Mar

Is Heron Therapeutics, Inc. (HRTX) The Hot Biotech Stock Under $5?

Insider Monkey
·
27 Mar

Heron Therapeutics, Inc. (NASDAQ:HRTX) Just Reported Earnings, And Analysts Cut Their Target Price

Simply Wall St.
·
02 Mar

Analysts Offer Insights on Healthcare Companies: Heron Therapeutics (HRTX), Milestone Pharmaceuticals (MIST) and Personalis (PSNL)

TIPRANKS
·
28 Feb

High Growth Tech Stocks to Watch in US Market February 2025

Simply Wall St.
·
28 Feb

Heron Therapeutics Price Target Maintained With a $4.00/Share by Needham

Dow Jones
·
28 Feb

Heron Therapeutics (NASDAQ:HRTX) shareholders are up 19% this past week, but still in the red over the last five years

Simply Wall St.
·
28 Feb

Heron Therapeutics Full Year 2024 Earnings: Beats Expectations

Simply Wall St.
·
28 Feb

Heron Therapeutics Inc (HRTX) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ...

GuruFocus.com
·
28 Feb

Q4 2024 Heron Therapeutics Inc Earnings Call

Thomson Reuters StreetEvents
·
28 Feb

Analysts’ Top Healthcare Picks: Heron Therapeutics (HRTX), DENTSPLY SIRONA (XRAY)

TIPRANKS
·
28 Feb

Heron Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
28 Feb

Heron Therapeutics (HRTX) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks
·
27 Feb

Heron Therapeutics: Q4 Earnings Snapshot

Associated Press Finance
·
27 Feb

Heron Therapeutics sees FY25 revenue $153M-$163M, consensus $160.63M

TIPRANKS
·
27 Feb

Heron Therapeutics Expects 2025 Sales Of $153M-$163M Versus Consensus Of $160.633M

Benzinga
·
27 Feb

Heron Therapeutics Q4 2024 GAAP EPS $0.02 Beats $(0.03) Estimate, Sales $40.78M Beat $37.37M Estimate

Benzinga
·
27 Feb

Heron Therapeutics Inc: Qtrly EPS $0.02

THOMSON REUTERS
·
27 Feb

Heron Therapeutics Inc: Outlook FY Net REV $153.0 Mln to $163.0 Mln

THOMSON REUTERS
·
27 Feb

Heron Therapeutics Q4 Net Income USD 3.663 Million

THOMSON REUTERS
·
27 Feb